Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density

OBJECTIVES: To evaluate the efficacy of raloxifene in preventing bone loss associated with long term gonadotropin-releasing hormone agonist (GnRH-a) administration. METHODS: Twenty-two premenopausal women with severe endometriosis were treated with leuprolide acetate depot at a dosage of 3.75 mg/4 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Young Hwa, Um, Mi Jung, Kim, Suk Jin, Kim, Soo Ah, Jung, Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Menopause 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256355/
https://www.ncbi.nlm.nih.gov/pubmed/28119898
http://dx.doi.org/10.6118/jmm.2016.22.3.174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256355/
https://www.ncbi.nlm.nih.gov/pubmed/28119898
http://dx.doi.org/10.6118/jmm.2016.22.3.174

Ejemplares similares